Literature DB >> 12221465

[Keloids. A fibroproliferative disorder of unknown etiology].

O Bock1, U Mrowietz.   

Abstract

We review recent advances in keloid research and treatment. Keloids are benign tumours of the skin. They tend to occur in younger patients after different kinds of injuries, infections or they may develop spontaneously. In contrast to hypertrophic scars, keloids are not confined to the original wound, but grow into the corresponding healthy skin. They rarely recede within time. Most patients complain of itching and suffer from impairment of their quality of life. Only little is known about the pathogenesis of keloids, although they have been clinically well characterized for a long time. New results point towards a disruption in the signaling pathway of TGFbeta. In addition there seems to be evidence of an increased familiar incidence and therefore the genetic background should be screened. Successful treatment of keloids is difficult. As contact cryotherapy and intralesional corticosteroid injections are in most cases not successful, the pulsed dye-laser seems to be a promising alternative. In addition topical treatment with extracts of onions, occlusive silicone sheets and pressure improves the clinical appearance of keloids.

Entities:  

Mesh:

Year:  2002        PMID: 12221465     DOI: 10.1007/s00105-001-0316-6

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  5 in total

1.  [Unclear connective tissue tumor].

Authors:  M Lehnert; K U Löffler
Journal:  Ophthalmologe       Date:  2004-12       Impact factor: 1.059

2.  Peripheral hypertrophic subepithelial corneal degeneration presenting with bilateral nasal and temporal corneal changes.

Authors:  M Schargus; C Kusserow; U Schlötzer-Schrehardt; C Hofmann-Rummelt; G Schlunck; G Geerling
Journal:  Eye (Lond)       Date:  2014-10-03       Impact factor: 3.775

3.  Fundamental aspects of arm repair phase in two echinoderm models.

Authors:  Cinzia Ferrario; Yousra Ben Khadra; Anna Czarkwiani; Anne Zakrzewski; Pedro Martinez; Graziano Colombo; Francesco Bonasoro; Maria Daniela Candia Carnevali; Paola Oliveri; Michela Sugni
Journal:  Dev Biol       Date:  2017-12-25       Impact factor: 3.582

4.  [Impact of TGF-beta1 antisense on collagen-binding integrins in keloid].

Authors:  G Bran; U Sommer; F Meinzer; U R Goessler; K Hörmann; F Riedel; H Sadick
Journal:  HNO       Date:  2010-06       Impact factor: 1.284

5.  Downregulation of CR6-interacting factor 1 suppresses keloid fibroblast growth via the TGF-β/Smad signaling pathway.

Authors:  Harsha Nagar; Sungmin Kim; Ikjun Lee; Seonhee Kim; Su-Jeong Choi; Shuyu Piao; Byeong Hwa Jeon; Sang-Ha Oh; Cuk-Seong Kim
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.